Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(50.0%)
N/A
1(50.0%)
2Total
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02893241Completed

Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting

Role: lead

NCT04637880Completed

25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders

Role: collaborator

NCT02202005Phase 1Completed

Multiple Dose BE Study With Nevirapine 400mg PR Tablets

Role: lead

NCT01107548Not ApplicableTerminated

Prevention of Stroke and Dementia in Primary Care

Role: collaborator

All 4 trials loaded